{"id":"https://openalex.org/W4282823964","doi":"https://doi.org/10.1172/jci.insight.160173","title":"Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera","display_name":"Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera","publication_year":2022,"publication_date":"2022-06-14","ids":{"openalex":"https://openalex.org/W4282823964","doi":"https://doi.org/10.1172/jci.insight.160173","pmid":"https://pubmed.ncbi.nlm.nih.gov/35700051","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9431671"},"language":"en","primary_location":{"id":"doi:10.1172/jci.insight.160173","doi":"https://doi.org/10.1172/jci.insight.160173","is_oa":true,"landing_page_url":"https://doi.org/10.1172/jci.insight.160173","pdf_url":"http://insight.jci.org/articles/view/160173/files/pdf","source":{"id":"https://openalex.org/S2764964142","display_name":"JCI Insight","issn_l":"2379-3708","issn":["2379-3708"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320279","host_organization_name":"American Society for Clinical Investigation","host_organization_lineage":["https://openalex.org/P4310320279"],"host_organization_lineage_names":["American Society for Clinical Investigation"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCI Insight","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://insight.jci.org/articles/view/160173/files/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001404007","display_name":"Pierre Roques","orcid":"https://orcid.org/0000-0003-1825-1054","observed_orcids":["https://orcid.org/0000-0003-1825-1054"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I4210097138","display_name":"CEA Paris-Saclay - Etablissement de Fontenay-aux-roses","ror":"https://ror.org/010j2gw05","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565"]},{"id":"https://openalex.org/I4210128565","display_name":"CEA Paris-Saclay","ror":"https://ror.org/03n15ch10","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210128565"]},{"id":"https://openalex.org/I4210128767","display_name":"Infectious Disease Models and Innovative Therapies","ror":"https://ror.org/03bk36k19","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210128767"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pierre Roques","raw_affiliation_strings":["Universit\u00e9 Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France"],"raw_orcid":"https://orcid.org/0000-0003-1825-1054","affiliations":[{"raw_affiliation_string":"Universit\u00e9 Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565","https://openalex.org/I4210128767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033436260","display_name":"Andrea Fritzer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151340","display_name":"Valneva (Austria)","ror":"https://ror.org/03xk4a758","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210151340"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Andrea Fritzer","raw_affiliation_strings":["Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria","institution_ids":["https://openalex.org/I4210151340"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007314757","display_name":"Nathalie Dereuddre\u2010Bosquet","orcid":"https://orcid.org/0000-0001-6682-6313","observed_orcids":["https://orcid.org/0000-0001-6682-6313"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I4210097138","display_name":"CEA Paris-Saclay - Etablissement de Fontenay-aux-roses","ror":"https://ror.org/010j2gw05","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565"]},{"id":"https://openalex.org/I4210128565","display_name":"CEA Paris-Saclay","ror":"https://ror.org/03n15ch10","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210128565"]},{"id":"https://openalex.org/I4210128767","display_name":"Infectious Disease Models and Innovative Therapies","ror":"https://ror.org/03bk36k19","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210128767"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nathalie Dereuddre-Bosquet","raw_affiliation_strings":["Universit\u00e9 Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France"],"raw_orcid":"https://orcid.org/0000-0001-6682-6313","affiliations":[{"raw_affiliation_string":"Universit\u00e9 Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565","https://openalex.org/I4210128767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013854296","display_name":"Nina Wressnigg","orcid":"https://orcid.org/0000-0002-2073-7582","observed_orcids":["https://orcid.org/0000-0002-2073-7582"]},"institutions":[{"id":"https://openalex.org/I4210151340","display_name":"Valneva (Austria)","ror":"https://ror.org/03xk4a758","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210151340"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Nina Wressnigg","raw_affiliation_strings":["Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria"],"raw_orcid":"https://orcid.org/0000-0002-2073-7582","affiliations":[{"raw_affiliation_string":"Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria","institution_ids":["https://openalex.org/I4210151340"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031442621","display_name":"Romana Hochreiter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151340","display_name":"Valneva (Austria)","ror":"https://ror.org/03xk4a758","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210151340"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Romana Hochreiter","raw_affiliation_strings":["Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria","institution_ids":["https://openalex.org/I4210151340"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060203160","display_name":"La\u00ebtitia Bossevot","orcid":"https://orcid.org/0000-0002-5752-9277","observed_orcids":["https://orcid.org/0000-0002-5752-9277"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I4210097138","display_name":"CEA Paris-Saclay - Etablissement de Fontenay-aux-roses","ror":"https://ror.org/010j2gw05","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565"]},{"id":"https://openalex.org/I4210128565","display_name":"CEA Paris-Saclay","ror":"https://ror.org/03n15ch10","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210128565"]},{"id":"https://openalex.org/I4210128767","display_name":"Infectious Disease Models and Innovative Therapies","ror":"https://ror.org/03bk36k19","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210128767"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laetitia Bossevot","raw_affiliation_strings":["Universit\u00e9 Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France"],"raw_orcid":"https://orcid.org/0000-0002-5752-9277","affiliations":[{"raw_affiliation_string":"Universit\u00e9 Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565","https://openalex.org/I4210128767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074860086","display_name":"Quentin Pascal","orcid":"https://orcid.org/0000-0001-5842-7080","observed_orcids":["https://orcid.org/0000-0001-5842-7080"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I4210097138","display_name":"CEA Paris-Saclay - Etablissement de Fontenay-aux-roses","ror":"https://ror.org/010j2gw05","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565"]},{"id":"https://openalex.org/I4210128565","display_name":"CEA Paris-Saclay","ror":"https://ror.org/03n15ch10","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210128565"]},{"id":"https://openalex.org/I4210128767","display_name":"Infectious Disease Models and Innovative Therapies","ror":"https://ror.org/03bk36k19","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210128767"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Quentin Pascal","raw_affiliation_strings":["Universit\u00e9 Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France"],"raw_orcid":"https://orcid.org/0000-0001-5842-7080","affiliations":[{"raw_affiliation_string":"Universit\u00e9 Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565","https://openalex.org/I4210128767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079891800","display_name":"Fabienne Gu\u00e9henneux","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fabienne Guehenneux","raw_affiliation_strings":["Valneva SE, Saint Herblain, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Valneva SE, Saint Herblain, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000309817","display_name":"Annegret Bitzer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151340","display_name":"Valneva (Austria)","ror":"https://ror.org/03xk4a758","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210151340"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Annegret Bitzer","raw_affiliation_strings":["Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria","institution_ids":["https://openalex.org/I4210151340"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038625321","display_name":"Irena Corbic Ramljak","orcid":"https://orcid.org/0000-0002-1127-7123","observed_orcids":["https://orcid.org/0000-0002-1127-7123"]},"institutions":[{"id":"https://openalex.org/I4210151340","display_name":"Valneva (Austria)","ror":"https://ror.org/03xk4a758","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210151340"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Irena Corbic Ramljak","raw_affiliation_strings":["Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria","institution_ids":["https://openalex.org/I4210151340"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032170909","display_name":"Roger Le Grand","orcid":"https://orcid.org/0000-0002-4928-4484","observed_orcids":["https://orcid.org/0000-0002-4928-4484"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I4210097138","display_name":"CEA Paris-Saclay - Etablissement de Fontenay-aux-roses","ror":"https://ror.org/010j2gw05","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565"]},{"id":"https://openalex.org/I4210128565","display_name":"CEA Paris-Saclay","ror":"https://ror.org/03n15ch10","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210128565"]},{"id":"https://openalex.org/I4210128767","display_name":"Infectious Disease Models and Innovative Therapies","ror":"https://ror.org/03bk36k19","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210128767"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Roger Le Grand","raw_affiliation_strings":["Universit\u00e9 Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France"],"raw_orcid":"https://orcid.org/0000-0002-4928-4484","affiliations":[{"raw_affiliation_string":"Universit\u00e9 Paris-Saclay, INSERM, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565","https://openalex.org/I4210128767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000369011","display_name":"Urban Lundberg","orcid":"https://orcid.org/0000-0001-9731-840X","observed_orcids":["https://orcid.org/0000-0001-9731-840X"]},"institutions":[{"id":"https://openalex.org/I4210151340","display_name":"Valneva (Austria)","ror":"https://ror.org/03xk4a758","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210151340"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Urban Lundberg","raw_affiliation_strings":["Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria"],"raw_orcid":"https://orcid.org/0000-0001-9731-840X","affiliations":[{"raw_affiliation_string":"Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria","institution_ids":["https://openalex.org/I4210151340"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004796046","display_name":"Andreas L. Meinke","orcid":"https://orcid.org/0009-0003-7413-2209","observed_orcids":["https://orcid.org/0009-0003-7413-2209"]},"institutions":[{"id":"https://openalex.org/I4210151340","display_name":"Valneva (Austria)","ror":"https://ror.org/03xk4a758","country_code":"AT","type":"company","lineage":["https://openalex.org/I4210151340"]}],"countries":["AT"],"is_corresponding":true,"raw_author_name":"Andreas Meinke","raw_affiliation_strings":["Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Valneva Austria GmbH, Campus Vienna Biocenter 3, Vienna, Austria","institution_ids":["https://openalex.org/I4210151340"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5004796046","https://openalex.org/A5032170909"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565","https://openalex.org/I4210128767","https://openalex.org/I4210151340"],"apc_list":{"value":4100,"currency":"USD","value_usd":4100},"apc_paid":{"value":4100,"currency":"USD","value_usd":4100},"fwci":12.522,"has_fulltext":true,"cited_by_count":83,"citation_normalized_percentile":{"value":0.99441088,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"7","issue":"14","first_page":"e160173","last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10166","display_name":"Mosquito-borne diseases and control","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10166","display_name":"Mosquito-borne diseases and control","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12047","display_name":"Viral Infections and Vectors","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chikungunya-virus","display_name":"chikungunya virus","score":0.9900000095367432},{"id":"https://openalex.org/keywords/live-attenuated-vaccine","display_name":"live attenuated vaccine","score":0.9919999837875366},{"id":"https://openalex.org/keywords/vaccine-effectiveness","display_name":"vaccine effectiveness","score":0.8080000281333923},{"id":"https://openalex.org/keywords/nonhuman-primates","display_name":"non-human primates","score":0.9359999895095825},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.6690000295639038},{"id":"https://openalex.org/keywords/plaque-reduction-neutralization-test","display_name":"plaque reduction neutralization test","score":0.8370000123977661},{"id":"https://openalex.org/keywords/viremia","display_name":"viremia","score":0.7099999785423279},{"id":"https://openalex.org/keywords/vaccine-licensure","display_name":"vaccine licensure","score":0.6949999928474426},{"id":"https://openalex.org/keywords/mosquito-borne-alphavirus","display_name":"mosquito-borne alphavirus","score":0.7900000214576721}],"concepts":[{"id":"https://openalex.org/C2781273456","wikidata":"https://www.wikidata.org/wiki/Q243257","display_name":"Chikungunya","level":3,"score":0.9581236243247986},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6834553480148315},{"id":"https://openalex.org/C2776185481","wikidata":"https://www.wikidata.org/wiki/Q1425304","display_name":"Viremia","level":3,"score":0.6641277074813843},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5783374905586243},{"id":"https://openalex.org/C116675565","wikidata":"https://www.wikidata.org/wiki/Q3241045","display_name":"Outbreak","level":2,"score":0.5296366214752197},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.5272437930107117},{"id":"https://openalex.org/C138894074","wikidata":"https://www.wikidata.org/wiki/Q7201694","display_name":"Plaque reduction neutralization test","level":4,"score":0.5154346227645874},{"id":"https://openalex.org/C32611913","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Titer","level":3,"score":0.48616549372673035},{"id":"https://openalex.org/C45189115","wikidata":"https://www.wikidata.org/wiki/Q502159","display_name":"Serology","level":3,"score":0.4819883704185486},{"id":"https://openalex.org/C2777474056","wikidata":"https://www.wikidata.org/wiki/Q1111605","display_name":"Alphavirus","level":3,"score":0.4765004515647888},{"id":"https://openalex.org/C2781313946","wikidata":"https://www.wikidata.org/wiki/Q4735280","display_name":"Alphavirus infection","level":4,"score":0.46719905734062195},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.43963623046875},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.17350992560386658}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002646","descriptor_name":"Chikungunya virus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014613","descriptor_name":"Vaccines, Attenuated","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016036","descriptor_name":"Seroepidemiologic Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065632","descriptor_name":"Chikungunya Fever","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1172/jci.insight.160173","doi":"https://doi.org/10.1172/jci.insight.160173","is_oa":true,"landing_page_url":"https://doi.org/10.1172/jci.insight.160173","pdf_url":"http://insight.jci.org/articles/view/160173/files/pdf","source":{"id":"https://openalex.org/S2764964142","display_name":"JCI Insight","issn_l":"2379-3708","issn":["2379-3708"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320279","host_organization_name":"American Society for Clinical Investigation","host_organization_lineage":["https://openalex.org/P4310320279"],"host_organization_lineage_names":["American Society for Clinical Investigation"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCI Insight","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9431671","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9431671","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCI Insight","raw_type":"Text"},{"id":"pmid:35700051","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35700051","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCI insight","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:cea-04841193v1","doi":null,"is_oa":true,"landing_page_url":"https://cea.hal.science/cea-04841193","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"https://insight.jci.org/articles/view/160173","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:ec90b07cb5d944d2bbe9bde3d450847d","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/ec90b07cb5d944d2bbe9bde3d450847d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"JCI Insight, Vol 7, Iss 14 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1172/jci.insight.160173","doi":"https://doi.org/10.1172/jci.insight.160173","is_oa":true,"landing_page_url":"https://doi.org/10.1172/jci.insight.160173","pdf_url":"http://insight.jci.org/articles/view/160173/files/pdf","source":{"id":"https://openalex.org/S2764964142","display_name":"JCI Insight","issn_l":"2379-3708","issn":["2379-3708"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320279","host_organization_name":"American Society for Clinical Investigation","host_organization_lineage":["https://openalex.org/P4310320279"],"host_organization_lineage_names":["American Society for Clinical Investigation"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JCI Insight","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.979200005531311}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3279886564","display_name":null,"funder_award_id":"Valneva 0001","funder_id":"https://openalex.org/F4320316507","funder_display_name":"Coalition for Epidemic Preparedness Innovations"},{"id":"https://openalex.org/G5344229298","display_name":"Infrastructure nationale pour la mod\u00e9lisation des maladies infectieuses humaines","funder_award_id":"ANR-11-INBS-0008","funder_id":"https://openalex.org/F4320320883","funder_display_name":"Agence Nationale de la Recherche"},{"id":"https://openalex.org/G5802621812","display_name":null,"funder_award_id":"ANR-11-INBS","funder_id":"https://openalex.org/F4320320883","funder_display_name":"Agence Nationale de la Recherche"}],"funders":[{"id":"https://openalex.org/F4320316507","display_name":"Coalition for Epidemic Preparedness Innovations","ror":"https://ror.org/02j9wvt50"},{"id":"https://openalex.org/F4320320883","display_name":"Agence Nationale de la Recherche","ror":"https://ror.org/00rbzpz17"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4282823964.pdf","grobid_xml":"https://content.openalex.org/works/W4282823964.grobid-xml"},"referenced_works_count":47,"referenced_works":["https://openalex.org/W268526039","https://openalex.org/W1594042551","https://openalex.org/W1668099561","https://openalex.org/W1733753318","https://openalex.org/W1963749198","https://openalex.org/W2004476696","https://openalex.org/W2021045663","https://openalex.org/W2035587893","https://openalex.org/W2041247701","https://openalex.org/W2064659419","https://openalex.org/W2068012691","https://openalex.org/W2070608209","https://openalex.org/W2079902751","https://openalex.org/W2104296094","https://openalex.org/W2112497696","https://openalex.org/W2118159889","https://openalex.org/W2119791199","https://openalex.org/W2120979836","https://openalex.org/W2127568306","https://openalex.org/W2134624539","https://openalex.org/W2136631930","https://openalex.org/W2141231462","https://openalex.org/W2145610587","https://openalex.org/W2156559833","https://openalex.org/W2157730228","https://openalex.org/W2158045389","https://openalex.org/W2159624858","https://openalex.org/W2166606211","https://openalex.org/W2167217912","https://openalex.org/W2169463345","https://openalex.org/W2240113735","https://openalex.org/W2396806161","https://openalex.org/W2555627680","https://openalex.org/W2559978238","https://openalex.org/W2560446953","https://openalex.org/W2585999323","https://openalex.org/W2597732596","https://openalex.org/W2655976600","https://openalex.org/W2804754774","https://openalex.org/W2892247894","https://openalex.org/W2911184439","https://openalex.org/W2990620950","https://openalex.org/W3014720962","https://openalex.org/W3031762331","https://openalex.org/W3095198749","https://openalex.org/W3171875158","https://openalex.org/W4229009493"],"related_works":["https://openalex.org/W4402466362","https://openalex.org/W4410298961","https://openalex.org/W7170142146","https://openalex.org/W4376879923","https://openalex.org/W4389657038","https://openalex.org/W7118463289","https://openalex.org/W4380369908","https://openalex.org/W3030013064","https://openalex.org/W4407910323","https://openalex.org/W2103230759"],"abstract_inverted_index":{"Chikungunya":[0,12],"virus":[1],"(CHIKV)":[2],"is":[3,30,180],"a":[4,24,71,122,135,147,174],"reemerging":[5],"mosquito-borne":[6],"alphavirus":[7],"responsible":[8],"for":[9,178],"numerous":[10],"outbreaks.":[11],"can":[13],"cause":[14],"debilitating":[15],"acute":[16],"and":[17,26,69,91,110,163],"chronic":[18],"disease.":[19],"Thus,":[20],"the":[21,39,42,153,161,171,189],"development":[22],"of":[23,41,55,74,129,137,144,155,168,173,176],"safe":[25],"effective":[27],"CHIKV":[28,44,49,68,89,112],"vaccine":[29,45,185],"an":[31,156,181],"urgent":[32],"global":[33],"health":[34],"priority.":[35],"This":[36],"study":[37],"evaluated":[38],"effectiveness":[40],"live-attenuated":[43],"VLA1553":[46,80,179],"against":[47],"WT":[48,67,97],"infection":[50],"by":[51,142,193],"using":[52],"passive":[53,119],"transfer":[54,102,120],"sera":[56,81],"from":[57,88,105,111,146],"vaccinated":[58],"volunteers":[59],"to":[60,66,83,160,187],"nonhuman":[61],"primates":[62],"(NHP)":[63],"subsequently":[64],"exposed":[65],"established":[70],"serological":[72],"surrogate":[73,136,175],"protection.":[75],"We":[76],"demonstrated":[77],"that":[78],"human":[79],"transferred":[82],"NHPs":[84],"conferred":[85],"complete":[86],"protection":[87,177],"viremia":[90],"fever":[92],"after":[93],"challenge":[94],"with":[95],"homologous":[96],"CHIKV.":[98],"In":[99,150],"addition,":[100],"serum":[101],"protected":[103],"animals":[104],"other":[106],"CHIKV-associated":[107],"clinical":[108],"symptoms":[109],"persistence":[113],"in":[114],"tissue.":[115],"Based":[116],"on":[117],"this":[118],"study,":[121],"50%":[123],"micro-plaque":[124],"reduction":[125],"neutralization":[126],"test":[127],"titer":[128],"\u2265":[130],"150":[131],"was":[132,140],"determined":[133],"as":[134],"protection,":[138],"which":[139],"supported":[141],"analysis":[143],"samples":[145],"seroepidemiological":[148],"study.":[149],"conclusion,":[151],"considering":[152],"unfeasibility":[154],"efficacy":[157],"trial":[158],"due":[159],"unpredictability":[162],"explosive,":[164],"rapidly":[165],"moving":[166],"nature":[167],"chikungunya":[169],"outbreaks,":[170],"definition":[172],"important":[182],"step":[183],"toward":[184],"licensure":[186],"reduce":[188],"medical":[190],"burden":[191],"caused":[192],"chikungunya.":[194]},"counts_by_year":[{"year":2026,"cited_by_count":21},{"year":2025,"cited_by_count":22},{"year":2024,"cited_by_count":24},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2022-06-15T00:00:00"}